METC Grand Rounds Series ''The Al Automation Paradox''

Activity Code: API-02-P301

Date: Wedensday, November 4, 2026

Speaker: Dr. Raja-Elie Abdulnour

Learning Objectives:

At the end of this activity participants will be able to:

1. Describe the current state of general-purpose Al in clinical practice.

2. Summarize the risks and perils of using Al in medicine.

3. Apply a framework for responsible use of clinical Al tools.

To be able to register for the activity, you MUST first Sign In to the portal.

The registration closes ONE day before the activity. You will receive a UNIQUE link to join the webinar on the day of the presentation.

Location: Livestreamed (Zoom)
Specialties: Allied Health Professionals, Dentists, Nurses, Pharmacists, Physicians, Students.

1. Describe the current state of general-purpose Al in clinical practice.
2. Summarize the risks and perils of using Al in medicine.
3. Apply a framework for responsible use of clinical Al tools.

No Registration Fee

Registration Warning

Registration for courses and events managed by Weill Cornell Medicine-Qatar (WCM-Q) can only be completed through the official WCM-Q registration portal. Registrations made through any other websites or third-party platforms cannot be honored.

Please report any unauthorized websites or solicitations for registration to [email protected].

DHP 

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 1 hour.

ACCME

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this Live Activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to the Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CE/CPD activities are intended to be evidence-based and free of commercial bias. 

Scientific Planning Committee: Thurayya Arayssi, MD, Anna Halama, PhD, Ali Hallal, MD, Aicha Hind Rifai, MD, Moune Jabre, MD, Mange Manyama, MD, PhD, Robert ojiambo, PhD, Kadhija Ziana Vamanjoor, BDS, MFDS, RCS, Mark D Santos, RN, BSN, CNS, Leena Amine, PharmD, Soha Osman, OT, Deema Al-Sheikhly, MRes, MEHP, Mohamed Ali Hammami, MBA, Frantzeska Gkioka, MBA. 

Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products

Jamie M. Gray, MLS, has disclosed the following relationships: Stocks or Stock Options, excluding diversified mutual funds - Proctor & Gamble, Colgate-Palmolive and Intuitive Surgical Inc, Crisper Therapeutics, Dexcom.

 All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated; WILL NOT BE DISCUSSING any unlabelled/unapproved use of drugs or products.

Course Directors: Thurayya Arayssi, MD, Anna Halama, PhD
Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products.

Independent Content Reviewer (ICR): Anna Halama, PhD, Has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products.

Course faculty: Dr. Jean Decety. 

Has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products.

Dr. Raja-Elie Abdulnour has disclosed the following relationships: Employment at Massachusetts Medical Society and Consulting Fee at Lumeris.

 All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated; WILL NOT BE DISCUSSING any unlabelled/unapproved use of drugs or products.

Administrative Contact: Tamara Al-kateb, BBA, Hana Hameed, Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.

Dr. Anna Halama 

Mitigation of Relevant Financial Relationships

Weill Cornell Medicine-Qatar adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Wednesday, November 4, 2026